Clinical Trial Update: Dose-Escalation and Safety Study of APC-100 for the Treatment of Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Dose-escalation and safety study of APC-100 in prostate cancer conducted in Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• APC-100

Snippet

Sponsor: Adamis Pharmaceuticals Corporation | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: UNKNOWN